History 2019-03-22T11:11:54+09:00

Company History

    2016

Feb 2016 Cell2in Inc. Established (CEO: Heun Soo Kang, Ph.D)
June 2016 Certificated business affiliated laboratory (Korea Industrial Technology Association)
Certificated Venture company (Korea Technology Finance Corporation)
Sep 2016 Korea Technology Finance Corporation Investment ($500,000)
Oct 2016 Government R&D grant (Korea Ministry of SMEs and Startups, $100,000)
MTA Contract : Hanyang Univ. College of Medicine
Nov 2016 MTA Contract : Seoul National Univ. College of Medicine, Konkuk Univ.
Dec 2016 Government R&D grant (Korea Ministry of Health and Welfare, $2,900,000)
MTA Contract : Ulsan Univ. College of Medicine

    2017

Mar 2017 Government R&D grant (IP-R&D, Korea Intellectual Property Office, $100,000)
Apr 2017 BioKorea 2017 (Presentation of FreSHtracer platform technology)
May 2017 MTA Contract : R company (Italy), K company
June 2017 Patent application to Korea
July 2017 Government R&D grant (Korea Ministry of Science and ICT, $3,000,000)
Patent application to (USA: 1, Korea: 2)
Joint Research Contract : M company
NDA/MTA Contract : R company
Aug 2017 CKD Venture Capital Corporation Investment ($700,000)
Sep 2017 Government R&D grant (Korea Ministry of trade, industry and energy, $400,000)
KSSCR 2017 (Presentation of FreSHtracer platform technology)
Oct 2017 Start selling Research products of FreSHtracer
Nov 2017 BioEurope 2017 (Presentation of FreSHtracer platform technology)
NDA Contract : T company (Spain)
Dec 2017 Family company of Korea Research Institute of Bioscience & Biotechnology
NDA/MTA Contract : J company (Japan), DB company

    2018

Jan 2018 Published in Stem Cell Report journal with FreSHtracer platform technology
Published in JCI journal with FreSHtracer platform technology
Certificated a special military service provider (Ministry of National Defense)
Reported to the Press  about FreSHtracer platform technology (Korea Health Industry Development Institute)
MTA Contract : Sookmyung Univ.
NDA contraction : B company (China), C company (Israel)
Joint Research Contract with H company
May 2018 NDA Contract : D company
BioKorea 2018 (Presentation of FreSHtracer platform technology)
June 2018 NDA contraction: A company (US)
ISSCR 2018 (Presentation of FreSHtracer platform technology)
Patent License Agreement Contract: D company
July 2018 Patent License Agreement Contract: I company, J-ARM (Japan)
Patent application to a PCT
Joint Research Contract with the Catholic Unversity of Korea, College of Medicine
Aug 2018 KSSCR 2018 (Presentation of FreSHtracer platform technology)
Sep 2018 MTA Contract (NIST,USA-Korea))
International Joint Research Contract with Cellect, Israel
Oct 2018 Government R&D grant (Korea Ministry of SMEs and startups, $450,000)
Government R&D grant (Korea Ministry of Health and Welfare, $1,500,000)
NDA contraction : K company (Japan)
Nov 2018 Government R&D grant (Korea Ministry of SMEs and startups, $50,000)
International Joint Research grant with Cellect, Israel (Korea-Isrel Industrial R&D Foundation, $60,000)
Patent application to two PCT
Dec 2018 Joint Research Contract of Animal disease Stem cell Therapy with C animal hospital
Honest Ventures Investment ($ 1,000,000)
Dong-Yu technology Corporation Investment ($1,000,000)

    2019

Mar 2019

Published in IJSC journal with Monitoring Glutathione Dynamics and Heterogeneity in Living Stem Cells